InvestSMART

Little Green Pharma Ltd (ASX:LGP)

ALERT: Price-sensitive ASX Announcement for LGP
Current share price for LGP : $0.073 -0.022 (-23.16%)+
Announcement
Release
25 May 2026 5:03PM
Price at Release
$0.095
Full Release
download
Summary
The Federal Court of Australia has approved the scheme of arrangement whereby Little Green Pharma Ltd (LGP) will acquire 100% of the issued capital of Cannatrek Ltd. This approval makes the scheme legally effective, with the court orders being lodged with the Australian Securities and Investments Commission (ASIC). The acquisition is set to be implemented on June 1, 2026, when Cannatrek shareholders will receive the scheme consideration. LGP, a global medicinal cannabis company, anticipates that this merger will expand its market presence further across various export markets, enhancing its growth trajectory and market leverage in the medicinal cannabis sector.
Key Points
  • Federal Court of Australia approves scheme for LGP to acquire Cannatrek.
  • Court orders lodged with ASIC make the scheme legally effective.
  • Implementation of the scheme scheduled for June 1, 2026.
  • Cannatrek shareholders to receive scheme consideration.
  • LGP is a leading medicinal cannabis company with operations in Europe and Australia.
  • Merger expected to enhance LGP's market presence and growth in the medicinal cannabis market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.